https://www.aigom.it/wp-content/uploads/2025/11/ART25.11.png1193743Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-25 11:13:322025-11-25 11:13:32CLINICAL CHARACTERIZATION OF FGFR2b EXPRESSION IN PATIENTS WITH ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
https://www.aigom.it/wp-content/uploads/2025/11/ART18.11-1.png738588Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-18 12:11:462025-11-25 13:01:27ESGO-ESTRO-ESP GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ENDOMETRIAL CARCINOMA: UPDATE 2025.
https://www.aigom.it/wp-content/uploads/2025/11/Screenshot-2025-11-13-115635.png1061840Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-13 11:06:102025-11-13 11:06:103 DICEMBRE 2025-ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE PASCALE-CANCRO E OBESITA’: UN FORTE LEGAME SPESSO “NASCOSTO”
https://www.aigom.it/wp-content/uploads/2025/11/Screenshot-2025-11-13-114115.png691967Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-13 10:55:132025-11-13 10:55:1328 NOVEMBRE 2025 ANCONA-MARCANGOLO XVII
https://www.aigom.it/wp-content/uploads/2025/11/Screenshot-2025-11-13-100837.png10361440Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-13 09:18:202025-11-13 09:18:2019-20 NOVEMBRE 2025 ROMA-4° CONGRESSO NAZIONALE FONICAP-LILT-IL TRATTAMENTO DEI TUMORI TORACICI UP-DATE POST ASCO/IASLC/ESMO/AIOM 2025
https://www.aigom.it/wp-content/uploads/2025/11/ART11.11.png1104750Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-11 10:06:582025-11-11 10:06:58FIRST-LINE CAMIZESTRANT FOR EMERGING ESR1-MUTATED ADVANCED BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2025/11/ART4.11.png1264819Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-04 08:26:532025-11-04 08:26:53PHYSICIANS’ KNOWLEDGE, PRACTICE, AND ATTITUDES ON FERTILITY AND PREGNACY-RELATED ISSUES IN YOUNG WOMEN WITH ADVANCED BREAST CANCER: RESULTS OF THE ABC6 AND ABC7 SURVEY.
